Article
Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care
3 Jan 2024
Abstract excerpt
Gene therapy holds promise as a life-changing option for individuals with genetic variants that give rise to disease. FDA-approved gene therapies for Spinal Muscular Atrophy (SMA), cerebral adrenoleukodystrophy, β-Thalassemia, hemophilia A/B, retinal dystrophy, and Duchenne Muscular Dystrophy have generated buzz around the ability to change the course of genetic syndromes. However, this excitement risks...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
